BioCentury | Mar 17, 2014
Clinical News

Cellvizio regulatory update

Mauna Kea said FDA granted 510(k) clearance for Cellvizio optical biopsy device for use during urological procedures within anatomical tracts, including the urethra, bladder and ureter. The clearance covers the use of Cellvizio's Uroflex B...
BioCentury | Dec 16, 1996
Strategy

Procter & Gamble Deal List

...consumer products. Terminated 01/95. 11/93 MicroProbe (now Epoch) Evaluate clinical efficacy of DNA probe-based diagnostics. MicroProbe...
BioCentury | Dec 11, 1995
Company News

Gen-Probe, Becton Dickinson deal

...company. Becton Dickinson also agreed to participate in defending Gen-Probe's patents against infringement. In October, MicroProbe Corp....
BioCentury | Dec 4, 1995
Company News

MicroProbe, Becton Dickinson deal

...MPRO completed the sale of its diagnostic business and the MicroProbe name to Becton Dickinson's Diagnostics...
...Inc. Epoch will focus on oligonucleotide-based gene therapies for viral and genetic diseases and cancer. MicroProbe Corp....
BioCentury | Oct 9, 1995
Company News

MicroProbe, Gen-Probe, Becton Dickinson Diagnostic Instrument Systems deal

...MPRO's Affirm product line. Gen-Probe's 1993 suit in U.S. District Court in San Diego accused MicroProbe...
...of detecting, identifying and quantifying organisms using probes targeting nucleic acids containing ribosomal RNA sequences. MicroProbe Corp....
BioCentury | Feb 21, 1995
Finance

Blech holdings put into fund

...percent of Advanced Surgical Inc. (ASUR), 24 percent of LXR Biotechnology (LXR), 24 percent of MicroProbe Corp....
BioCentury | Oct 17, 1994
Company News

MicroProbe deal

...said. "P&G will market the product, so it's something they will have to deal with." MicroProbe Corp....
BioCentury | Oct 3, 1994
Finance

Waiting for other shoes to drop

...to close a $3.75 million tranche from a Blech-placed funding. The BTGC situation follows on MicroProbe Corp....
BioCentury | Aug 15, 1994
Company News

MicroProbe other research news

...approach, MPRO said, will make results available 24 to 48 hours sooner than existing methods. MicroProbe Corp....
BioCentury | May 9, 1994
Strategy

MPRO Sacrifices Disputed Product

...MPRO sacrifices disputed product MicroProbe Corp. withdrew its Affirm VP line of DNA probe-based products from the...
...tests for pathogens associated with vaginitis, posted $1 million in sales last year. It was MicroProbe's...
Items per page:
1 - 10 of 24
BioCentury | Mar 17, 2014
Clinical News

Cellvizio regulatory update

Mauna Kea said FDA granted 510(k) clearance for Cellvizio optical biopsy device for use during urological procedures within anatomical tracts, including the urethra, bladder and ureter. The clearance covers the use of Cellvizio's Uroflex B...
BioCentury | Dec 16, 1996
Strategy

Procter & Gamble Deal List

...consumer products. Terminated 01/95. 11/93 MicroProbe (now Epoch) Evaluate clinical efficacy of DNA probe-based diagnostics. MicroProbe...
BioCentury | Dec 11, 1995
Company News

Gen-Probe, Becton Dickinson deal

...company. Becton Dickinson also agreed to participate in defending Gen-Probe's patents against infringement. In October, MicroProbe Corp....
BioCentury | Dec 4, 1995
Company News

MicroProbe, Becton Dickinson deal

...MPRO completed the sale of its diagnostic business and the MicroProbe name to Becton Dickinson's Diagnostics...
...Inc. Epoch will focus on oligonucleotide-based gene therapies for viral and genetic diseases and cancer. MicroProbe Corp....
BioCentury | Oct 9, 1995
Company News

MicroProbe, Gen-Probe, Becton Dickinson Diagnostic Instrument Systems deal

...MPRO's Affirm product line. Gen-Probe's 1993 suit in U.S. District Court in San Diego accused MicroProbe...
...of detecting, identifying and quantifying organisms using probes targeting nucleic acids containing ribosomal RNA sequences. MicroProbe Corp....
BioCentury | Feb 21, 1995
Finance

Blech holdings put into fund

...percent of Advanced Surgical Inc. (ASUR), 24 percent of LXR Biotechnology (LXR), 24 percent of MicroProbe Corp....
BioCentury | Oct 17, 1994
Company News

MicroProbe deal

...said. "P&G will market the product, so it's something they will have to deal with." MicroProbe Corp....
BioCentury | Oct 3, 1994
Finance

Waiting for other shoes to drop

...to close a $3.75 million tranche from a Blech-placed funding. The BTGC situation follows on MicroProbe Corp....
BioCentury | Aug 15, 1994
Company News

MicroProbe other research news

...approach, MPRO said, will make results available 24 to 48 hours sooner than existing methods. MicroProbe Corp....
BioCentury | May 9, 1994
Strategy

MPRO Sacrifices Disputed Product

...MPRO sacrifices disputed product MicroProbe Corp. withdrew its Affirm VP line of DNA probe-based products from the...
...tests for pathogens associated with vaginitis, posted $1 million in sales last year. It was MicroProbe's...
Items per page:
1 - 10 of 24